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1107-139 Metabolic Syndrome Is Highly Prevalent in Patients 
With Coronary Artery Disease 
Prakash C. Deedwania, Nini C. Thomas, Kern Brar, VA Central California Health Care 
System, Fresno. CA, UCSF School of Medicine, San Francisco, CA 
Backqround: Recent Adult Treatment Panel III (ATP Ill) guidelines have emphasized the 
sigmficance of metabolic syndrome (MS) as an important risk factor for coronary artery 
disease (CAD). However, the prevalence of MS in CAD patients is not known. Accord- 
ingly, we evaluated the prevalence of MS among patients with established diagnosis of 
CAD at our Medical Center. 
Method: A random group of 668 patients with established diagnosis of CAD was selected 
from computer records of VACCHCS. Fresno. Patients’ age, HR, BP, height, weight, 
body mass index, FBS. and total, LDL and HDL cholesterols were recorded. History of 
treatment for diabetes. hypertension, or dyskpidemia was also recorded. Diagnosis of 
MS was based on ATP Ill guidelines. Statistical analyses were done using the Chi- 
Square test for categorical variables and the t-test. for continuous vanables. 
Results: The study population consisted of 668 men with CAD (mean age 69 yrs). Of 
these, 570 were found to have MS, giving a prevalence of 75% (Cl 72%-78%, p value < 
,001). Of the MS patients, 77% and 87% were found to have dyslipidemia and hyperten- 
sion, respectively (p value < .OOOl for both). The table below shows the mean values of 
Important variables in patients with (+) and without (-) MS 
Conclusion: These data suggest that MS is highly prevalent among patients with CAD. 
Future prospective studies should evaluate the risk of CAD in patients with MS. 
Variable Metabolic Syndrome + Metabolic Syndrome - P-value 
Age (years) 69 71 0.014 
Pulse (bpm) 69 70 0.307 
Systolic (mm Hg) 141 130 0.015 
Diastolic (mm Hg) 72 69 0.004 
BMI (kg/n?) 31 26 0.0001 
T. Cholesterol (mg/dl) 179 174 0.198 
LDL (mg/dl) 99 106 0.07 
HDL (mg/dl) 43 46 0.158 
FBS (mgdl) 133 103 o.oooi 
1107-140 The Impact of Moderate Elevations of Blood Pressure 
and Low-Density Lipoprotein Chlosterol on Coronary 
Heart Disease Risk 
Peter W. Wilson. Ralph B. D’Agostino, Sr.. Lisa Sullwan, Daniel Levy. Boston University, 
Boston, MA, National Heart, Lung, and Blood Institute, Framingham, MA 
The effects of moderately elevated lipid levels and blood pressure on coronary heart dis- 
ease (CHD) nsk were examined in Framingham Heart Study participants 30-74 years of 
age at baseline. Risk factors assessed included systolic blood pressure (SBP). LDL cho- 
lesterol (LDL-C), age, sex. diabetes status, and history of cigarette smoking. SEP cate- 
gories (<140, 140.159,>160 mm Hg) and LDL-C levels (<loo, 100-129, 130.159, ,160 
mg/dl) were key components in the analyses. Men and women contributed 3952 and 
4489 person-exams of experience respectively and were followed 12 years for the onset 
of new CHD (angina pectoris. myocardial infarction or coronary death). Analyses used 
age-adjusted Cox models and persons with highly elevated SEIP, highly elevated LDL-C, 
or moderate elevations of both factors experienced greater CHD risk in comparisons with 
a referent group that had SBP ~140 mm Hga LDL-C < 100 mgidl (see table, where * 
denotes P<O.Ol vs referent after age adjustment). Furthermore, moderately elevated 
LDL-C and SBP frequently coexist and the CHD risk related to this combination did not 
differ from that for the highly elevated LDL-C or highly elevated SBP groups. These 
results emphasize the need for awareness, diagnosis and treatment of persons with 
moderately increased blood pressure and lipld levels. 
Group 
BP, LDL-C and CHD R,sk 
Group Criteria Frequency IOyrCHD 
(umts mm Hg and mg/dl) Men I risk 
Women Men i 
Women 
Referent 
Mod Elev SBP and 
LDL-C 
Highly Elev LDL-C 
Highly Elev SBP 
SBP cl40 and LDL-C cl00 11 %ll7% 5%/0.7% 
SBP (140-259) and LDL-C (100. lis/d 8% 17%./l 2%’ 
159) 
LDL-C>tGO 25%l25% 19%‘/12%’ 
SBP 1160 7%/7% 24%*/l 4/%’ 
1107-141 Decreased Activities of Paraoxonase and High-Density- 
Lipoprotein Associated Platelet Activating Factor 
Acetylhydrolase in Hemodialysis Patients 
Bo Zhanq, Satoshi Eta, Ping Fan, Eiso Shimoji. Keijiro Saku. Fukuoka University, 
Fukuoka, Japan 
Background: HDL IS antlatherogenlc partly because of its antloxidatlve and antm-flamma- 
tory properties, in which paraoxonase (Pant), which protects LDL from oxidation, and 
HDL-associated PAF acetylhydrolase (PAF-AH), which degrades PAF and orldizes 
phosphatidylcholine, play an important role. Since patients with chronic renal failure have 
an increased cardiovascular risk and reduced HDL-C levels, we examined whether 
patients on hemodlalysis (HD) have altered activities of Ponl and HDL-associated PAF- 
AH (HDL-PAF-AH). 
Methods: Eighty-seven male non-diabetic HD patients and 73 normal male subjects were 
measured with regard to serum lipids, lipoproteins, Ponl activity with paraoxon as sub- 
strate, and plasma PAF-AH activity and HDL-PAF-AH activity with a specific substrate 
(Azwell Inc.). 
Results: Ponl and HDL-PAF-AH were correlated with HDL-C levels (r=0.30 and 0.38. 
p<O.Ol) in all of the subjects. HD patients had lower (~~0.05) levels of TC, TG, HDL-C, 
and plasma PAF-AH (391 * 155 vs. 453 r 145 /U/L) than controls. Activities of Ponl (770 
* 242 vs. 1014 f 379 IV/L) and HDL-PAF-AH (75 f 26 vs. 117 * 36 IU/L) were also lower 
(~~0.05) in HD patients than in controls. Similar results were obtained after adjusting for 
HDL-C (Rgure) by a General Linear Model, suggestmg that Ponl and HDL-PAF-AH 
were associated with chronic renal failure independent of serum HDL-C levels. 
Conclusion: The reduced Ponl and HDL-associated PAF-AH may contribute to cardio- 
vascular risk independent of HDL-C levels in HD patients. 
1107-142 Comparative Value of Carotid Ultrasound, High 
Sensitivity C-Reactive Protein, and Low-Oensitv 
Lipoprotein Particle Size in Predicting Coronar; Artery 
Disease in Young Adults 
Kwame 0. Akosah, Sharon I. Barnhart. Troy Haider, Pat Perlock, Jo Bistodeau. Ana M. 
Schaper, Gundersen Lutheran Medical Center, La Crosse, WI 
Background: Preventing premature coronary artery disease (CAD) has been difficult. 
We have previously reported that many young adults suffering myocardial infarctions do 
not have high cholesterol and that the National Cholesterol Education Program guide- 
lines (NCEP Ill) fail to appreciate disease risk. Our objective was to evaluate high sensi- 
tivity C-reactive protein (Hs-CRP), low dense lipoprotein (LDL) particle size, and carotid 
ultrasound (CU) for the ability to predict angiographic CAD in a group of young adults 
scheduled for coronary angiography. 
Method Subjects scheduled for elective cardiac catheterization were recruited. Subjects 
underwent CU and had blood drawn for Hs-CRP, LDL particle size, and lipoprotein anal- 
ysis (LPA). Subjects were excluded for age (women >65 and men >55 years), Statin ther- 
apy, or known CAD or equivalent. Any coronary stenosis was considered evtdence of 
angiographic disease and aO% stenosis was considered severe disease. Criteria for 
abnormal CU included intima media thickness >l.O cm, focal plaque or calcium deposits. 
Risk score for a tan-year probability of cardiac event was calculated for each patient as 
per the NCEP Ill guidelines. 
Results 147 subjects (73 women, mean age 54 and 74 men, mean age 47) completed 
all tests. LPA was as follows: total 209 +/- 46 mg/dL, LDL 131 +/- 38 mg/dL, HDL 48 +/- 
15 m@dL, and triglyceride 159 +/- 87 m@dL. 20% of subjects had LDL cholesterol < 100 
mgldL and only 17% had >t 60 m@dL. 58 subjects had normal CU and 87 were abnor- 
mal. 75 subjects had normal angiograms and 70 had disease. The sensitivity for CU 
compared to angiogram was 70%. with a negative predictive value of 70% (p = 0.013). 
The odds ratio (OR) for abnormal CU in predicting angiographic disease was 2.3 (Cl: 1.5 
- 4.5). The sensitivity for small dense LDL was 44% specificity 56% (OR: 1.5; Cl: 0.76 
2.9, p = ns). The OR for CRP was 1.3 (p = 0.5, Cl: 0.65 - 2.5). Multiple regression 
revealed that only CU abnormalities independently predicted coronary angiographic dis- 
ease. LDL particle size and Hs-CRP had no additional benefit. 
Conclusion: In the evaluation of premature CAD in young adults with low cholesterol, 
CU predicts angiographic disease and is superior to LDL particle size and Hs-CRP. 
1107-143 Which Lipid/Lipoprotein Ratio Best Predicts 
Angiographic Coronary Artery Disease? 
Tami L. Bair, Joseph B. Muhlestein. John F. Carlquist. Chloe A. Allen Maycock. Robert 
R. Pearson, Sandra P. Reyna. Benjamm D. Home, Jeffrey L. Anderson, LDS Hospital, 
Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Backgrounct Various lipid or lipoprotein (LP) ratios have been proposed as a single, 
composite lipid-related risk factor (i.e., total cholesterol [TC]/high density lipoprotein cho- 
lesterol [HDLJ, low density lipoprotein-C [LDL]/HDL, non-HDUHDL, and triglycerides 
[TG]/HDL). These derived measures have not, however, been assessed and compared 
as predictors of angiographic coronary artery disease (CAD). 
Methods We evaluated the predictive value for angiographic CAD of TC/HDL, LDU 
HDL, non-HDUHDL, and TG/HDL ratios, and individual LP fractions in a consecutive 
serves of consenting, prospectively assessed patients. Acute Ml at presentation was 
excluded. Fasting LPs were measured at the time of angiography after an overnight fast 
and assayed by colorimety (Vitros 950). Anglography was performed prior to LP and LP 
ratio determinations. Analysis used logistic regression. 
Results Patients (N=4,724) averaged 63113 years of age; 66% were male. Significant 
CAD @70% stenosl?.) was found in 54%, mild/moderate CAD I” ll%, and no CAD 
